401 related articles for article (PubMed ID: 10067896)
1. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.
Ulloa L; Doody J; Massagué J
Nature; 1999 Feb; 397(6721):710-3. PubMed ID: 10067896
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta attenuates the class II transactivator and reveals an accessory pathway of IFN-gamma action.
Nandan D; Reiner NE
J Immunol; 1997 Feb; 158(3):1095-101. PubMed ID: 9013947
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium avium infection of mouse macrophages inhibits IFN-gamma Janus kinase-STAT signaling and gene induction by down-regulation of the IFN-gamma receptor.
Hussain S; Zwilling BS; Lafuse WP
J Immunol; 1999 Aug; 163(4):2041-8. PubMed ID: 10438942
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1.
Ting LM; Kim AC; Cattamanchi A; Ernst JD
J Immunol; 1999 Oct; 163(7):3898-906. PubMed ID: 10490990
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta suppression of IFN-gamma-induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2, or signal transducers and activators of transcription, or modification of IFN-gamma enhanced factor X expression.
Panek RB; Lee YJ; Benveniste EN
J Immunol; 1995 Jan; 154(2):610-9. PubMed ID: 7814871
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
7. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3.
Higashi K; Inagaki Y; Fujimori K; Nakao A; Kaneko H; Nakatsuka I
J Biol Chem; 2003 Oct; 278(44):43470-9. PubMed ID: 12917425
[TBL] [Abstract][Full Text] [Related]
9. Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection.
Monteleone G; Del Vecchio Blanco G; Palmieri G; Vavassori P; Monteleone I; Colantoni A; Battista S; Spagnoli LG; Romano M; Borrelli M; MacDonald TT; Pallone F
Gastroenterology; 2004 Mar; 126(3):674-82. PubMed ID: 14988821
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.
Wicks SJ; Lui S; Abdel-Wahab N; Mason RM; Chantry A
Mol Cell Biol; 2000 Nov; 20(21):8103-11. PubMed ID: 11027280
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma inhibits transforming growth factor-beta production in human airway epithelial cells by targeting Smads.
Wen FQ; Liu X; Kobayashi T; Abe S; Fang Q; Kohyama T; Ertl R; Terasaki Y; Manouilova L; Rennard SI
Am J Respir Cell Mol Biol; 2004 Jun; 30(6):816-22. PubMed ID: 14722222
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model.
Kuga H; Morisaki T; Nakamura K; Onishi H; Noshiro H; Uchiyama A; Tanaka M; Katano M
Oncogene; 2003 Oct; 22(49):7838-47. PubMed ID: 14586410
[TBL] [Abstract][Full Text] [Related]
13. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.
Monteleone G; Kumberova A; Croft NM; McKenzie C; Steer HW; MacDonald TT
J Clin Invest; 2001 Aug; 108(4):601-9. PubMed ID: 11518734
[TBL] [Abstract][Full Text] [Related]
14. Unexpected transcriptional signals in normal and mitotically defective cells mediated through cytokine and growth factor receptors.
Samanta A; Qian X; Greene MI
DNA Cell Biol; 1995 Nov; 14(11):921-30. PubMed ID: 7576178
[TBL] [Abstract][Full Text] [Related]
15. STAT1-independent down-regulation of interferon-gamma-induced class II transactivator and HLA-DR expression by transforming growth factor beta-1 in human glomerular endothelial cells.
Yang WS; Han NJ; Kim CS; Ahn H; Lee SK; Lee KU; Park SK
Nephron Exp Nephrol; 2005; 100(3):e124-31. PubMed ID: 15824515
[TBL] [Abstract][Full Text] [Related]
16. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads.
Weng H; Mertens PR; Gressner AM; Dooley S
J Hepatol; 2007 Feb; 46(2):295-303. PubMed ID: 17125875
[TBL] [Abstract][Full Text] [Related]
17. Receptor-associated Mad homologues synergize as effectors of the TGF-beta response.
Zhang Y; Feng X; We R; Derynck R
Nature; 1996 Sep; 383(6596):168-72. PubMed ID: 8774881
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta/Smad signaling inhibits IFN-gamma and TNF-alpha-induced TARC (CCL17) production in HaCaT cells.
Sumiyoshi K; Nakao A; Setoguchi Y; Tsuboi R; Okumura K; Ogawa H
J Dermatol Sci; 2003 Feb; 31(1):53-8. PubMed ID: 12615364
[TBL] [Abstract][Full Text] [Related]
19. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism.
Schiller M; Verrecchia F; Mauviel A
Oncogene; 2003 Dec; 22(55):8881-90. PubMed ID: 14654784
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling.
Seo T; Park J; Choe J
Cancer Res; 2005 Mar; 65(5):1738-47. PubMed ID: 15753369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
